Who owns ENTRADA THERAPEUTICS INC?
- Ticker: TRDA
- CUSIP Number: 29384c108
Tip: Access positions for across all investors
Analyze quarterly positions in Entrada Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Entrada Therapeutics stock
Who bought or sold ENTRADA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Baker Bros. Advisors | 4.9M | $69M | 0% | Mar 2024 |
|
| MPM Asset Management | 4.4M | $63M | 0% | Mar 2024 |
|
| 5AM Venture Management | 4.4M | $63M | 0% | Mar 2024 |
|
| T. Rowe Price Associates | 2.8M | $39M | -9% | Mar 2024 |
|
| BlackRock | 1.5M | $21M | 6% | Mar 2024 |
|
| Redmile Group | 1.3M | $18M | 0% | Mar 2024 |
|
| Vanguard Group | 1.1M | $15M | 1% | Mar 2024 |
|
| Wellington Management Company | 1.0M | $16M | 0% | Dec 2023 |
|
| StepStone | 761k | $11M | 0% | Mar 2024 |
|
| Geode Capital Management | 475k | $6.7M | 8% | Mar 2024 |
|
| American Century Companies | 366k | $5.2M | 164% | Mar 2024 |
|
| Northern Trust | 199k | $2.8M | -3% | Mar 2024 |
|
| FMR | 168k | $2.4M | -71% | Mar 2024 |
|
| Charles Schwab Investment Management | 157k | $2.2M | 3% | Mar 2024 |
|
| Bank of New York Mellon | 111k | $1.6M | -4% | Mar 2024 |
|
| Morgan Stanley | 108k | $1.5M | 414% | Mar 2024 |
|
| Moore Capital Management | 105k | $1.5M | 0% | Mar 2024 |
|
| Advantage Alpha Capital Partners | 91k | $1.3M | 100% | Mar 2024 |
|
| Millennium Management | 72k | $1.0M | 200% | Mar 2024 |
|
| TD Asset Management | 71k | $1.0M | -40% | Mar 2024 |
|
| Citadel Advisors | 70k | $987k | 100% | Mar 2024 |
|
| Nuveen Asset Management | 57k | $810k | -22% | Mar 2024 |
|
| Citigroup | 56k | $788k | 1710% | Mar 2024 |
|
| Marshall Wace | 52k | $733k | 100% | Mar 2024 |
|
| Corton Capital | 41k | $583k | 44% | Mar 2024 |
|
| Squarepoint Ops | 34k | $483k | 100% | Mar 2024 |
|
| Winton Capital | 33k | $461k | 100% | Mar 2024 |
|
| Natixis | 31k | $433k | 0% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 31k | $436k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 30k | $418k | 3% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 29k | $410k | 100% | Mar 2024 |
|
| New York Life Investment Management | 26k | $367k | 100% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 26k | $364k | 7% | Mar 2024 |
|
| UBS Group | 24k | $333k | 4% | Mar 2024 |
|
| Swiss National Bank | 23k | $326k | 0% | Mar 2024 |
|
| Bank of America Corporation | 23k | $320k | -18% | Mar 2024 |
|
| Barclays | 23k | $318k | -29% | Mar 2024 |
|
| Oracle Alpha | 17k | $246k | 39% | Mar 2024 |
|
| Goldman Sachs Group | 17k | $246k | -4% | Mar 2024 |
|
| Man Group | 17k | $238k | 100% | Mar 2024 |
|
| Credit Suisse | 16k | $228k | 1% | Mar 2024 |
|
| Allspring Global Investments Holdings | 15k | $209k | 428% | Mar 2024 |
|
| Harbor Capital Advisors | 15k | $206k | 100% | Mar 2024 |
|
| Franklin Resources | 14k | $203k | 8% | Mar 2024 |
|
| Arrowstreet Capital, Limited Partnership | 14k | $203k | 100% | Mar 2024 |
|
| CornerCap Investment Counsel | 13k | $186k | 100% | Mar 2024 |
|
| California State Teachers Retirement System | 13k | $179k | -16% | Mar 2024 |
|
| PDT Partners | 13k | $178k | 100% | Mar 2024 |
|
| MetLife Investment Advisors | 12k | $177k | 0% | Dec 2023 |
|
| Legal & General Group | 11k | $157k | 0% | Mar 2024 |
|
| American International | 11k | $161k | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 10k | $143k | 3% | Mar 2024 |
|
| New York State Common Retirement Fund | 8.9k | $126k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 8.4k | $119k | -41% | Mar 2024 |
|
| SG Americas Securities | 7.7k | $109k | -34% | Mar 2024 |
|
| Wells Fargo & Company | 7.6k | $108k | 15% | Mar 2024 |
|
| Acadian Asset Management | 5.7k | $79k | 100% | Mar 2024 |
|
| Lazard Asset Management | 2.7k | $40k | 100% | Dec 2023 |
|
| New York State Teachers Retirement System | 1.9k | $27k | 100% | Mar 2024 |
|
| Summit Investment Advisors | 1.8k | $25k | 0% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.2k | $18k | 0% | Dec 2023 |
|
| Royal Bank of Canada | 1.1k | $16k | -84% | Mar 2024 |
|
| Plato Investment Management | 1.1k | $16k | 100% | Mar 2024 |
|
| Federated Investors | 908.00 | $14k | 100% | Dec 2023 |
|
| Amalgamated Bank | 721.00 | $10k | -61% | Mar 2024 |
|
| Tower Research Capital | 435.00 | $6.2k | -57% | Mar 2024 |
|
| GAMMA Investing | 40.00 | $567.000000 | 100% | Mar 2024 |
|
| NISA Investment Advisors | 31.00 | $439.000300 | 210% | Mar 2024 |
|
| Russell Investments | 9.00 | $127.999800 | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 4.00 | $56.000000 | 100% | Mar 2024 |
|
| CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Entrada Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| 72 Investment Holdings | Dec 2023 | 173k | $2.6M |
| Mirae Asset Global Investments | Dec 2023 | 11k | $164k |
| State of Wyoming | Dec 2023 | 5.9k | $90k |